Skip to main content
Premium Trial:

Request an Annual Quote

Praxis Precision Medicines: Tim Kelly

Tim Kelly has become CFO of Praxis Precision Medicines, a biopharmaceutical company translating genetic results into treatments for central nervous system disorders. He joins the Cambridge, Massachusetts-based firm from Foundation Medicine, a subsidiary of Roche, where he was CFO and head of corporate management. Prior to that, he held various roles at Roche, most recently finance and corporate services director at Roche Pharma in the UK. Kelly holds a BA in economics from the College of William and Mary and an MBA from Columbia Business School.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.